Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Francisco Javier Salgado Castro"'
Autor:
Sara Vázquez Mera, Pablo Miguéns-Suárez, Laura Martelo-Vidal, Uxío Calvo-Álvarez, Javier Rodríguez-García, Coral González-Ferández, Mar Mosteiro-Añón, Marina Blanco-Aparicio, Juan José Nieto-Fontarigo, Francisco Javier Salgado-Castro, Francisco Javier González-Barcala
Publikováno v:
Allergy and immunology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35206e961c5e44856a729e2cf9453945
https://doi.org/10.1183/23120541.lsc-2022.97
https://doi.org/10.1183/23120541.lsc-2022.97
Autor:
Ana G. Abril, Rubén Agregán, Rituparna Banerjee, Jorge Barros-Velázquez, Subhasish Biswas, S.B. Bravo, Pilar Calo-Mata, Mónica Carrera, M.D.P. Chantada-Vázquez, Anand Raj Dhanapal, Ruben Dominguez, Noemí Echegaray, Natalya Fedoseeva, Daniel Franco Ruiz, Mohammed Gagaoua, Francisco Javier González-Barcala, María López Pedrouso, Jose M. Lorenzo, Naveena Basappa Maheswarappa, Kiran Mohan, Paulo E.S. Munekata, Juan José Nieto-Fontarigo, C. Núñez, Mirian Pateiro, Maksim Rebezov, Francisco Javier Salgado Castro, M. Wes Schilling, Enrique Sentandreu, Miguel Ángel Sentandreu, Mohammad Ali Shariati, Robert Stryiński, Surendranath Suman, Muthu Thiruvengadam, Baskar Venkidasamy, Tomás G. Villa, Sol Zamuz, Xue Zhang, Yao Zhu, Elżbieta Łopieńska-Biernat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::383d48314b48cd4a128721bfa87d3d98
https://doi.org/10.1016/b978-0-323-90889-4.00037-3
https://doi.org/10.1016/b978-0-323-90889-4.00037-3
Autor:
Miguel-Ángel García-González, Jose-Domingo Moure-Gonzalez, María-Esther San-José-Capilla, Tania Liñares-Mata, Ana Faraldo-García, Montserrat Nogueira, Pablo Martin-Lancharro, Francisco-Javier González-Barcala, Francisco-Javier Salgado-Castro, Pilar Arias, Carmen Diego-Roza, Juan-José Nieto-Fontarigo, El-Bahi Takkouche-Souilamas, Luis Valdés-Cuadrado, José-Martín Carreira-Villamor
Publikováno v:
Allergy and immunology.
In 2003, FDA approved Omalizumab for the treatment of severe allergic asthma. This mAb recognizes IgE and blocks its binding to basophils and mast cells, attenuating FceRI signalling. Nevertheless, its effect on T helper (Th) subsets like regulatory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f018a8cad997f084c2b5726f5dbb293e
https://doi.org/10.1183/13993003.congress-2018.oa1649
https://doi.org/10.1183/13993003.congress-2018.oa1649
Autor:
El Bahi Takkouche Souilamas, Juan José Nieto Fontarigo, Montserrat Nogueira Álvarez, Ana Faraldo Garcia, Francisco Javier Salgado Castro, Luis Valdés Cuadrado, Maria Esther San Jose Capilla, María Jesús Cruz, Francisco Javier González Barcala, Pilar Arias Crespo, Jose Martin Carreira Villamor, Miguel Angel Garcia Gonzalez
Publikováno v:
Allergy and immunology.
The role of effector TH cells (Teff; CD25 low CD127 high ) like TH17 lymphocytes in asthma depends on their interplay with regulatory T cells (Treg; CD25 high CD127 low ), which display low levels of CD26 (TH17>>TH1>TH2>>Treg) but high of LRRC32. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::398801b8adee1519ccda05a396c879fb
https://doi.org/10.1183/1393003.congress-2017.oa4847
https://doi.org/10.1183/1393003.congress-2017.oa4847
Autor:
Francisco-Javier Salgado-Castro, Francisco-Javier González-Barcala, Esther San-José, Nuria García-Couceiro, David Facal, Uxio Calvo-Alvarez, Xavier Muñoz, Jose-Martín Carreira, Maria-Teresa Garcia-Sanz, Luis Valdés-Cuadrado, Olalla Paz-Neira
Publikováno v:
Acta clinica Belgica. 72(6)
Hospital admissions account for a significant part of asthma cost, but with significant differences between geographic areas.The aim of our study is to analyse hospital admissions due to asthma, as well as the factors associated with longer hospital
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1e6d7b2bd811fb754b30d9ee31336a1
https://pubmed.ncbi.nlm.nih.gov/28245723
https://pubmed.ncbi.nlm.nih.gov/28245723
Autor:
Oj, Cordero, Fj, Salgado, Cm, Fernández-Alonso, Herrera C, Lluis C, Francisco Javier Salgado Castro, Nogueira M
Publikováno v:
Europe PubMed Central
CD26 is a lymphocyte marker that can anchor adenosine deaminase (ADA) on the T cell surface. We found that ADA is regulated by cytokines on the cell surface during T cell activation. By means of flow cytometry, immunofluorescence, and immunoblotting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2efe84b5634ac32462c80fc05366f339
http://europepmc.org/abstract/med/11739555
http://europepmc.org/abstract/med/11739555